Dutch firm Philips Electronics said the waiting period under the U.S. Hart-Scott-Rodino antitrust act has expired for its planned acquisition of nuclear medicine and radiation therapy firm ADAC Laboratories. Last month Philips announced its plan to buy Milpitas, CA-based ADAC for about $426 million, or $18.50 per share.
By AuntMinnie.com staff writers
December 8, 2000
Philips to re-enter nuclear medicine market with bid to buy ADAC, November 13, 2000
Copyright © 2000 AuntMinnie.com